Pregabalin 71209-0038-04
- Manufacturer
- Cadila Pharmaceuticals Limited
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- July 13, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA206452
Active Ingredients
| Ingredient | Strength |
|---|---|
| Pregabalin | 225 mg/1 |
Selected Package
71209-0038-04Selected90 CAPSULE in 1 BOTTLE (71209-038-04)